↓ Skip to main content

A Multinational, Observational Study to Investigate the Efficacy, Safety and Tolerability of Acarbose as Add-On or Monotherapy in a Range of Patients: The GlucoVIP Study

Overview of attention for article published in Clinical Drug Investigation, February 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
39 Mendeley
Title
A Multinational, Observational Study to Investigate the Efficacy, Safety and Tolerability of Acarbose as Add-On or Monotherapy in a Range of Patients: The GlucoVIP Study
Published in
Clinical Drug Investigation, February 2013
DOI 10.1007/s40261-013-0063-3
Pubmed ID
Authors

Weiwei Zhang, DongJun Kim, Elizabeth Philip, Zahid Miyan, Irina Barykina, Birgit Schmidt, Herbert Stein

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 3%
Brazil 1 3%
Unknown 37 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 23%
Student > Bachelor 6 15%
Student > Master 5 13%
Student > Postgraduate 4 10%
Researcher 3 8%
Other 5 13%
Unknown 7 18%
Readers by discipline Count As %
Medicine and Dentistry 13 33%
Agricultural and Biological Sciences 4 10%
Nursing and Health Professions 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Engineering 3 8%
Other 7 18%
Unknown 6 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2018.
All research outputs
#7,499,357
of 22,919,505 outputs
Outputs from Clinical Drug Investigation
#269
of 964 outputs
Outputs of similar age
#64,625
of 193,714 outputs
Outputs of similar age from Clinical Drug Investigation
#2
of 14 outputs
Altmetric has tracked 22,919,505 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 964 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,714 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.